8-KThe WireRoutine
Shareholder Vote
Filed Jun 4, 2026 · 25d ago · Accession 0001193125-26-257394
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Stoke Therapeutics, Inc.
- Ticker
- STOK
- CIK
- 1623526
- Form type
- 8-K
- Filing date
- Jun 4, 2026
- Report date
- Jun 3, 2026
- Document
- d15052d8k.htm
- Size
- 138 KB